Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 141.30 4.40
Tata Mot 428.65 4.24
Bhel 181.05 3.10
Tata Stl 418.80 1.22
Ntpc Ltd 123.05 0.37
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Suven Life Sciences Limited
Suven Life Sciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530239NSE:SUVENBloomberg:SVLS@INReuters:SUVP.BO
Market Lot: 1Face Value: 1ISIN Demat: INE495B01038
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
10-APR-14 Suven Life Sciences (Suven) announced that the grant of one product patent from Hong Kong and one product patent from Canada corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2023 and 2029 respectively. 26-MAR-14 Suven Life Sciences (Suven), a biopharmaceutical company, announces today that the grant of two product patents f...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Suven Life bags two patents for NCEs in Canada, HK  -IRIS 10-Apr-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2013(9)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 3795.092578.852038.27
Other Income41.1910.4319.11
Total Income3836.282589.282057.38
Cost of goods sold2101.792046.991805.30
OPBDIT1734.49542.29252.08
PAT1117.52308.40155.22
Gross Block---
Equity capital116.83116.83116.73
EPS (Rs.)-2.641.33
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-5.09 - 13.358.65 - 19.32
Debt / Equity (x)---
Operating margin (% of OI)45.220.912.3
Net margin (% of OI)29.111.9 7.5
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
SDE Serene Chambers
Road No 5
Banjara Hills
Hyderabad
Andhra Pradesh-500 034
PHONE
(040) 2354 1142/ 3311
FAX
(040) 2354 1152
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer